Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Study of Obeticholic Acid for Lipodystrophy Patients

NCT02430077 is registered in ClinicalTrials.gov with Abhimanyu Garg as lead sponsor.

NCT NCT02430077
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02430077 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Study of Obeticholic Acid for Lipodystrophy Patients
Lead sponsor
Abhimanyu Garg
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2016
Completion date
December 31, 2022
Enrollment
10 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

familial partial lipodystrophy